Keywords: elan, in-licenses, gw, ultiva, pharma, ltd, signed

Elan in-licenses GW's Ultiva

Article | 27 January 2000

Print This

Elan Pharma Ltd has signed a deal to in-license Glaxo Wellcome'sintravenous analgesic Ultiva (remifentanil HCl) for the UK market.

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in